科拓生物：2025年半年度净利润约4121万元

Core Viewpoint - The company reported a year-on-year increase in revenue for the first half of 2025, but a decline in net profit and earnings per share [2] Financial Performance - The company's revenue for the first half of 2025 was approximately 163 million yuan, representing an 18.32% increase compared to the previous year [2] - The net profit attributable to shareholders was around 41.21 million yuan, which is a decrease of 5.31% year-on-year [2] - Basic earnings per share were 0.16 yuan, reflecting a decline of 5.88% compared to the same period last year [2]